WebFeb 5, 2024 · Bioventus intends to raise $125 million in gross proceeds from an IPO of its Class A common stock, offering 7.35 million shares at a proposed midpoint price of $17.00 per share. WebApr 4, 2024 · DURHAM, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has ...
Bioventus Announces Change in Chief Executive Officer
WebMay 7, 2012 · Headquartered in Durham, N.C., Bioventus grew out of Smith & Nephew’s former Biologics and Clinical Therapies division and includes nearly 500 U.S. employees … WebApr 4, 2024 · Bioventus ended last year with about $31.8 million in cash and $418.1 million of debt outstanding. Prior to its recent earnings call, the company announced it had amended a debt agreement with its ... shape playdough mats
Bioventus Inc. (BVS) CEO Ken Reali on Q3 2024 Results - Earnings …
WebEstablished in 2012, Bioventus Inc. (Nasdaq: BVS) is headquartered in Durham, NC. The company has more than 1,200 employees worldwide through its offices in Memphis, TN; Valencia, CA; Farmingdale, NY and Mississauga, Ontario, Canada; its international … Ken Reali Katrina Church Leigh Ann Stradford John Nosenzo Tony D'Adamio … WebDescription. Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and … WebApr 10, 2024 · When is Bioventus's earnings date? Bioventus has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 9th, 2024 based off last year's report dates. Learn more on BVS's earnings history. How much revenue does Bioventus generate each year? pony express half marathon marysville ks